Elicit: Efficacy of SGLT Activators on Water Absorption (public)
How effective are sodium-glucose cotransport activators in improving water absorption?
Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.
Abstract
Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.
Methods
We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.
Papers identified with Elicit search
- n = 997
Papers screened using: SGLT Activators/Enhancers, Water Absorption Outcome, In Vivo Studies, Appropriate Study Design, SGLT Activators vs Inhibitors, Beyond In Vitro Only, Publication Quality
- n = 997
Papers screened out
- n = 968
Papers included for extraction
- n = 29
Results
Water Absorption Outcomes
| Study | Activator Type | Water Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased water absorption | “Very significant increase” | No mention found |
| Rongione et al., 2001 | Epidermal Growth Factor, Transforming Growth Factor | Increased water absorption | Not quantified | Significant |
| Grahammer et al., 2006 | Dexamethasone | No mention found | N/A | N/A |
| Aguero et al., 1990 | Glutamine | Increased water absorption | Not quantified | Not significant (p>0.05) |
| Elliott et al., 1986 | Glucose (oral rehydration solution) | Increased water absorption | +98.6±16 microliters/minute/gram (ratio 1.9) | p<0.01 |
Sodium Absorption Outcomes
| Study | Activator Type | Sodium Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
| Rongione et al., 2001 | Epidermal Growth Factor, Transforming Growth Factor | Increased sodium absorption | Not quantified | Significant |
| Grahammer et al., 2006 | Dexamethasone | Increased SGLT1/NHE3 activity | Approximately 3x increase (wild type) | Significant |
| Aguero et al., 1990 | Glutamine | Increased sodium absorption | 300% increase | p>0.05 |
| Elliott et al., 1986 | Glucose (oral rehydration solution) | No mention found | N/A | N/A |
Comparative Effectiveness of Different Activators
| Study | Activator(s) Compared | Relative Effectiveness | Notes |
|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate, glycine | Alanine/protein hydrolysate > glycine | Alanine/protein hydrolysate most effective at higher sodium |
| Aguero et al., 1990 | Glutamine vs. control | Glutamine increased sodium absorption 300% | Both normal and diarrheic rats |
Context-Dependent Effects and Generalizability
- Most evidence is from animal models, which limits direct translation to human clinical settings.
- The magnitude of effect was often greater in diarrheal or secretory models (such as cholera, rotavirus, Escherichia coli) than in healthy controls, as reported in the included studies.
- Hormones (aldosterone, Angiotensin II) and drugs (tacrolimus, Teduglutide) were reported to modulate SGLT1 activity, sometimes suppressing (aldosterone) or enhancing (Teduglutide) absorption.
References
The content has been cleaned to focus solely on the main research findings, methodologies, results, and discussions without any extraneous navigation links, advertisements, or unrelated content.